Active Pharmaceutical Ingredients (APIs)

  • Trimetazidine Di HCI

    • API Product   :   

      Trimetazidine Di HCI

    • CEP   :   

      -

    • WCC   :   

      ?

    • Therapeutic Use    :   

      Cardiac therapy; Cerebral and peripheral vasotherapeutics

    • Originator   :   

      Servier

    • CAS No.    :   

      5011-34-7

    • Trade Name.   :   

      Vastarel

    • Molecular Weight   :   

      266.336 g/mol

    • Molecular Formula   :   

      C14H22N2O3

    Application

    Trimetazidine is a drug for angina pectoris sold under many brand names. ... Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.

    General Description

    Trimetazidine is a drug for angina pectoris sold under many brand names.[1] Trimetazidine is described as the first cytoprotective anti-ischemic agent developed and marketed by Laboratoires Servier (France). Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.